JP2005536516A5 - - Google Patents

Download PDF

Info

Publication number
JP2005536516A5
JP2005536516A5 JP2004522555A JP2004522555A JP2005536516A5 JP 2005536516 A5 JP2005536516 A5 JP 2005536516A5 JP 2004522555 A JP2004522555 A JP 2004522555A JP 2004522555 A JP2004522555 A JP 2004522555A JP 2005536516 A5 JP2005536516 A5 JP 2005536516A5
Authority
JP
Japan
Prior art keywords
alcohol
weight
amount
buffer
cetrimide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004522555A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005536516A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/008005 external-priority patent/WO2004009056A1/en
Publication of JP2005536516A publication Critical patent/JP2005536516A/ja
Publication of JP2005536516A5 publication Critical patent/JP2005536516A5/ja
Withdrawn legal-status Critical Current

Links

JP2004522555A 2002-07-23 2003-07-22 薬剤、軟膏基剤および可溶化剤/分散剤を含む、眼科用軟膏組成物 Withdrawn JP2005536516A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39786502P 2002-07-23 2002-07-23
PCT/EP2003/008005 WO2004009056A1 (en) 2002-07-23 2003-07-22 Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012014297A Division JP2012087146A (ja) 2002-07-23 2012-01-26 薬剤、軟膏基剤および可溶化剤/分散剤を含む、眼科用軟膏組成物

Publications (2)

Publication Number Publication Date
JP2005536516A JP2005536516A (ja) 2005-12-02
JP2005536516A5 true JP2005536516A5 (enExample) 2006-09-07

Family

ID=30771133

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004522555A Withdrawn JP2005536516A (ja) 2002-07-23 2003-07-22 薬剤、軟膏基剤および可溶化剤/分散剤を含む、眼科用軟膏組成物
JP2012014297A Pending JP2012087146A (ja) 2002-07-23 2012-01-26 薬剤、軟膏基剤および可溶化剤/分散剤を含む、眼科用軟膏組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012014297A Pending JP2012087146A (ja) 2002-07-23 2012-01-26 薬剤、軟膏基剤および可溶化剤/分散剤を含む、眼科用軟膏組成物

Country Status (8)

Country Link
US (2) US20060115500A1 (enExample)
EP (2) EP2319493A3 (enExample)
JP (2) JP2005536516A (enExample)
CN (2) CN101897662B (enExample)
AU (1) AU2003254566A1 (enExample)
BR (1) BR0312817A (enExample)
CA (1) CA2492989C (enExample)
WO (1) WO2004009056A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006019851A1 (en) * 2004-07-23 2006-02-23 Eli Lilly And Company Methods for diagnosing and treating diabetic microvascular complications
CN101123948A (zh) * 2005-02-17 2008-02-13 千寿制药株式会社 眼科用固体外用药剂
US20080112895A1 (en) * 2006-08-04 2008-05-15 Insys Therapeutics Inc. Aqueous dronabinol formulations
MX2010004373A (es) * 2007-11-01 2010-05-05 Bausch & Lomb Materiales miscibles en agua no acuosos como vehiculos para suministro de farmacos.
BR112012013812A2 (pt) 2009-12-08 2018-05-29 Healthpoint Ltd "composições para desbridamento enzimático de feridas com atividade enzimática melhorada"
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
CN108472312A (zh) 2015-09-28 2018-08-31 阿祖拉眼科有限公司 用于增加睑板腺脂质分泌物的含硫醇及二硫化物的药剂
CA3019349A1 (en) 2016-04-14 2017-10-19 Azura Ophthalmics Ltd. Selenium disulfide compositions for use in treating meibomian gland dysfunction
EP3741367A1 (en) * 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease
CA3166357A1 (en) 2020-01-10 2021-07-15 Azura Ophthalmics Ltd. Instructions for composition and sensitivity

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134718A (en) * 1963-12-12 1964-05-26 Schering Corp Pregna-1,4-dienes and compositions containing same
US3453257A (en) 1967-02-13 1969-07-01 Corn Products Co Cyclodextrin with cationic properties
GB1537047A (en) * 1975-10-03 1978-12-29 Fisons Ltd Eye ointment
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
JPS644125A (en) * 1987-06-26 1989-01-09 Hitachi Ltd Communication satellite identification system
IT1222309B (it) * 1987-07-08 1990-09-05 Menarini Sas Utilizzazione di forme farmaceutiche per uso topico contenenti miocamicina per la terapia delle infezione da germi sensibili alla miocamicina stessa
JP2865324B2 (ja) * 1989-09-29 1999-03-08 東京田辺製薬株式会社 9―メチル―3―(1H―テトラゾール―5―イル)―4H―ピリド[1,2―a]ピリミジン―4―オン又はその塩の軟膏剤
DK0427680T3 (da) 1989-11-09 1995-12-18 Sandoz Ltd Heteroatom-holdige cykliske forbindelser
US5241059A (en) 1990-05-21 1993-08-31 Toppan Printing Co., Ltd. Cyclodextrin derivatives
DE69125230T2 (de) 1990-09-04 1997-07-10 Fujisawa Pharmaceutical Co Tricyclische Verbindungen enthaltende Salben
DK196591D0 (da) * 1991-12-05 1991-12-05 Mouritsen & Elsner Aps Anvendelse af en kendt kemisk forbindelse til fremstilling af et farmaceutisk paraeparat til topisk applikation
HUT66531A (en) 1992-05-07 1994-12-28 Sandoz Ag Heteroatoms-containing tricyclic compounds, pharmaceutical prepns contg. them and process for producing them
MY110603A (en) 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
WO1995022331A1 (en) * 1994-02-18 1995-08-24 Cephalon, Inc. Aqueous indolocarbazole solutions
CA2201134A1 (en) * 1994-10-10 1996-04-18 Alfred Sallmann Ophthalmic and aural compositions containing diclofenac potassium
EP0711556A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Intravenöse Lösungen für ein Staurosporinderivat
WO1997008182A1 (en) 1995-08-24 1997-03-06 Merck & Co., Inc. Process for the preparation of imidazolyl macrolide immunosuppressants
JPH0977662A (ja) * 1995-09-11 1997-03-25 Zeria Pharmaceut Co Ltd 軟膏剤
UA54427C2 (uk) * 1996-05-01 2003-03-17 Елі Ліллі Енд Компані Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
JPH10203979A (ja) * 1997-01-24 1998-08-04 Rohto Pharmaceut Co Ltd チアプロフェン酸を含有する抗眼炎症剤
CO4960662A1 (es) 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
IT1295423B1 (it) * 1997-10-10 1999-05-12 Medivis S R L Uso della flunarizina nella terapia topica del glaucoma
FR2772271B1 (fr) * 1997-12-11 2000-09-01 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
CN1175904C (zh) * 1998-05-15 2004-11-17 若素制药株式会社 抗炎滴眼剂
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US6291519B1 (en) * 1998-10-14 2001-09-18 Novartis Ag Method of preventing damage to eye tissue
DE69912304T2 (de) * 1998-11-23 2004-07-22 Novartis Ag Verwendung von staurosporine derivaten zur behandlung von okularen neovaskularen erkrankungen
GB9903547D0 (en) * 1999-02-16 1999-04-07 Novartis Ag Organic compounds
ITMI991453A1 (it) * 1999-07-01 2001-01-01 Farmila Farma Milano Composizioni oftalmiche in forma di gel acquosi
US6271233B1 (en) 1999-08-10 2001-08-07 Ciba Vision Corporation Method for treating ocular neovascular diseases
HU226058B1 (en) * 2000-06-14 2008-04-28 Egis Gyogyszergyar Nyilvanosan Process for producing sterile acyclovir cream
CN1127955C (zh) * 2000-07-07 2003-11-19 中山医科大学中山眼科中心 一种眼前段及眼表免疫相关性疾病治疗药物
AR038628A1 (es) * 2002-03-04 2005-01-19 Novartis Ag Composicion oftalmica

Similar Documents

Publication Publication Date Title
JP3432855B2 (ja) フケ防止シャンプー中のチアゾリノン保存剤を安定化させるための亜鉛化合物の利用
JP2005536516A5 (enExample)
BR9901100A (pt) sos de controle do crescimento de fungos em um local e de puccinia spp., septoria spp. ou mofo pulverulento em trigo e para aumento do rendimento de plantações que estão infectadas por doenças de fungos.
JP2002509101A (ja) キレート化剤を含む、オートクレーブで処理できる医薬組成物
RU2009149687A (ru) Фармацевтические композиции и способы лечения сухих кератитов
NO20055401L (no) Fungisid blandinger for kontrollering av rispatogener
JP2001158734A (ja) 眼科用組成物及びソフトコンタクトレンズに対する吸着抑制方法
JP2010504358A5 (enExample)
RU99108250A (ru) Фунгицидная композиция
JP2012520882A5 (enExample)
JP2020111603A (ja) シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2001097865A (ja) 眼科用組成物
JP4849288B2 (ja) 点眼剤及び涙液膜の安定化剤
CN102308824B (zh) 一种含螺环菌胺与甲氧基丙烯酸酯类的杀菌组合物
CA1089357A (en) Fungicidal formulations
US7265117B2 (en) Topical brimonidine tartrate formulations that lack chlorine dioxide
BR0206494A (pt) Misturas fungicidas e método para combater fungos nocivos
CN108887269A (zh) 一种含有氟唑菌酰羟胺和琥胶肥酸铜的杀菌组合物
NO20060315L (no) Fungicidale blandinger
JP2001131055A (ja) 液剤、液剤の白濁解消方法及び液剤の経粘膜吸収促進方法
CA2244085A1 (en) Therapeutic anti-asthma agents containing selenium compounds
JP6940276B2 (ja) 花粉破裂抑制剤
JP6971570B2 (ja) 花粉破裂抑制剤
KR20120099365A (ko) 보존제로서 프로피온산 유도체를 함유하는 약제학적 안과 액제 조성물
CA2529290A1 (en) Pharmaceutical compositions comprising peranhydrocyclodextrin